CoronaryAtlas logo
CoronaryAtlas
Vasodilator-stimulated phosphoprotein
Pathway / Platelet adhesion & activation

Vasodilator-stimulated phosphoprotein

protein

VASP phosphorylation state reflects endothelial nitric oxide signaling and serves as a marker of platelet activation resistance.

Pathway placement
Cascade stepPlatelet adhesion & activation
Confidencemedium
RationaleNO/cGMP-dependent inhibitor of platelet activation; phosphorylation state marks anti-aggregatory signaling.
Druggability
Not assessed (no mapped human gene target).

Type I vs non-Type I discrimination

ScoresIndeterminate
R — rupture / Type-I
—
C — non-Type-I
40
A — assay feasibility
68
E — evidence strength
29
T1DI (composite)
7
Specificity differential (R−C)-25
Non-Type-I axis panel
Does this marker also move in each non-Type-I setting? mag 0–3; higher means less Type-I-specific. n/a = no evidence retrieved, which is not the same as no change.
2sepsis / systemic inflammationn/a
2anemia / acute blood lossn/a
2hypovolemia / dehydrationn/a
2tachyarrhythmiamag 1
2hypoxemia / respiratory failuren/a
2hypertensive emergencymag 1
2high-demand / peri-operative stressn/a
3sudden cardiac deathn/a
4aPCI-related periproceduraln/a
4bstent thrombosismag 2
4cin-stent restenosismag 1
5CABG-relatedmag 1
Coverage: 5/12 axes with evidence
Tier: deep-scored (abstract-extracted) · 8 supporting references. See the discrimination table for all markers.

Assay & specimen

Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)

Literature evidence(1)